Association Between Immune-Related Adverse Events and the Prognosis of Patients with Advanced Gastric Cancer Treated with Nivolumab.

Yoshiyasu KonoYasuhiro ChodaMasahiro NakagawaKoji MiyaharaMichihiro IshidaTetsushi KubotaKeiji SeoTetsu HirataYuka ObayashiTatsuhiro GotodaYuki MoritouYoshiko OkikawaYasuo IwamotoHiroyuki Okada

Published in: Targeted oncology (2021)

The development of irAEs might be associated with survival outcomes with nivolumab treatment in patients with AGC.

Keyphrases

neoadjuvant chemotherapy
squamous cell carcinoma
radiation therapy
newly diagnosed
rectal cancer
locally advanced